Sangamo Therapeutics, Inc. (SGMOQ)
0.1423
-0.02
(-11.17%)
USD |
OTCM |
Aug 21, 16:00
Sangamo Therapeutics Market Cap : 58.95M for Aug. 21, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 21, 2026 | 58.95M |
| August 20, 2026 | 66.37M |
| August 19, 2026 | 66.70M |
| August 18, 2026 | 66.08M |
| August 17, 2026 | 69.72M |
| August 14, 2026 | 72.50M |
| August 13, 2026 | 68.36M |
| August 12, 2026 | 63.59M |
| August 11, 2026 | 60.07M |
| August 10, 2026 | 48.88M |
| August 07, 2026 | 46.40M |
| August 06, 2026 | 46.19M |
| August 05, 2026 | 41.18M |
| August 04, 2026 | 36.91M |
| August 03, 2026 | 35.71M |
| July 31, 2026 | 30.32M |
| July 30, 2026 | 29.47M |
| July 29, 2026 | 28.50M |
| July 28, 2026 | 27.85M |
| July 27, 2026 | 26.72M |
| July 24, 2026 | 26.93M |
| July 23, 2026 | 30.24M |
| July 22, 2026 | 26.93M |
| July 21, 2026 | 27.34M |
| July 20, 2026 | 31.03M |
| Date | Value |
|---|---|
| July 17, 2026 | 26.93M |
| July 16, 2026 | 28.17M |
| July 15, 2026 | 26.93M |
| July 14, 2026 | 31.48M |
| July 13, 2026 | 30.24M |
| July 10, 2026 | 41.43M |
| July 09, 2026 | 34.80M |
| July 08, 2026 | 27.34M |
| July 07, 2026 | 28.32M |
| July 06, 2026 | 28.17M |
| July 02, 2026 | 31.03M |
| July 01, 2026 | 23.61M |
| June 30, 2026 | 22.33M |
| June 29, 2026 | 21.71M |
| June 26, 2026 | 18.64M |
| June 25, 2026 | 16.16M |
| June 24, 2026 | 18.65M |
| June 23, 2026 | 30.66M |
| June 22, 2026 | 72.19M |
| June 18, 2026 | 72.29M |
| June 17, 2026 | 73.95M |
| June 16, 2026 | 70.43M |
| June 15, 2026 | 68.36M |
| June 12, 2026 | 62.56M |
| June 11, 2026 | 60.07M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 12.24B |
| Oncolytics Biotech, Inc. | 105.94M |
| Sarepta Therapeutics, Inc. | 1.915B |
| Anixa Biosciences, Inc. | 122.97M |
| Vicapsys Life Sciences, Inc. | 46.94M |
Market Cap Related Metrics
| PS Ratio | 1.326 |
| Price | 0.1423 |
| Earnings Yield | -269.1% |